We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Patents pending

8 August 2007 By Robert Cyran

The company abandoned its Indian patent fight over a cancer drug. This may seem irrelevant it gives the drug away 99% of the time there. But its future depends on sales in a handful of developing countries. They could account for up to half its growth in the next five years.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)